Position in CDNA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$392,758
+$128,470 QoQ
Shares Held
13,781
-9.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#136
of 225 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026INTECH INVESTMENT MANAGEMENT LLC holds $57,283,725 across 27 Diagnostics & Research names. CDNA ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
20,897 | $10,476,919 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
14,380 | $7,615,504 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
10,493 | $5,523,934 | |
| 4 | QGEN |
Qiagen N.V.
|
129,327 | $5,056,685 | |
| 5 | DGX |
Quest Diagnostics Inc
|
20,375 | $4,318,480 | |
| 6 | DHR |
Danaher Corp /De/
|
20,940 | $3,988,650 | |
| 7 | NTRA |
Natera, Inc.
|
12,196 | $3,310,603 | |
| 8 | LH |
Labcorp Holdings Inc.
|
9,694 | $2,714,320 |
All Filings in CDNA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,758 | 13,781 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $264,288 | 15,224 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $401,612 | 21,317 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $309,949 | 21,317 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $551,496 | 28,224 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $533,565 | 30,060 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $415,246 | 19,395 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $449,015 | 14,380 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||